Skip Navigation

FDA panel recommends Pfizer vaccine for kids ages 5 to 11

The vaccine provides a broad defense against COVID-19 and 'effectively neutralized the delta variant' in this age group, said Pfizer's senior vice president of vaccine clinical research and development.

  • By Joe Neel, NPR
(Left to right): Brothers Justin Do, 9, and Joey Do, 4, of New Brunswick, have received two doses of the Pfizer vaccine, or a placebo, as part of a COVID-19 vaccine trial for kids under 12 at Rutgers University.

 Courtesy of Minh-Tu Do

(Left to right): Brothers Justin Do, 9, and Joey Do, 4, of New Brunswick, have received two doses of the Pfizer vaccine, or a placebo, as part of a COVID-19 vaccine trial for kids under 12 at Rutgers University.

Collage of two photos shows young boys, wearing masks, receiving vaccinations.

Courtesy of Minh-Tu Do

(Left to right): Brothers Justin Do, 9, and Joey Do, 4, of New Brunswick, have received two doses of the Pfizer vaccine, or a placebo, as part of a COVID-19 vaccine trial for kids under 12 at Rutgers University.

A panel of independent advisors to the Food and Drug Administration is recommending that the agency issue an emergency use authorization for the Pfizer-BioNTech vaccine in children ages 5 to 11 years old. The vote was 17 in favor and one abstention.

The FDA panel accepted Pfizer’s data indicating the vaccine is safe and 90.7% effective in preventing COVID-19 infections in this age group.

The agency typically goes along with the advice of its expert panels, though it isn’t bound to do so. It will issue a decision within the next several days. If the FDA authorizes the vaccine for younger children, as seems likely, another panel of experts advising the Centers for Disease Control and Prevention would make recommendations on its use for younger children next week.

The vaccine provides a broad defense against COVID-19 and “effectively neutralized the delta variant” in this age group, said Dr. William Gruber, senior vice president of vaccine clinical research and development at Pfizer, speaking during the committee hearing.

A dose of Pfizer for young children contains one-third the amount of active ingredient compared to the adult dose. Children would receive a second dose 21 days or more after their first shot.

Support for WITF is provided by:

Become a WITF sponsor today »

Support for WITF is provided by:

Become a WITF sponsor today »

Up Next
National & World News

US McDonald's workers strike to protest workplace harassment